Aphaia Pharma AG

ZG· Biopharmaceuticals

Bahnhofstrasse 28, 6300

Swiss Commercial Registry Listing

Aphaia Pharma AG is registered in the Swiss commercial registry. This listing is informational and has not yet been evaluated against the SwissMastery SSI™ criteria.

Overview

Aphaia Pharma AG is a clinical-stage biopharmaceutical company based in Zug, Switzerland, specializing in developing precision-targeted drug formulations for the treatment and prevention of metabolic disorders such as obesity and related diseases.

Company Information

Legal Form

Aktiengesellschaft

Municipality

Zug

Address

Bahnhofstrasse 28, 6300

Locality

Zug

Website

https://aphaiapharma.com

Industry Keywords

biopharmaceuticalsmetabolic disordersobesity treatmentdrug developmentprecision medicineclinical trialsendocrine balanceSwitzerland

Scoring Notes: Aphaia Pharma AG operates in the biopharmaceutical sector, focusing on medical treatments for metabolic disorders, which does not align with SwissMastery's emphasis on premium Swiss quality products and services.

Company profiles are informational listings and do not imply endorsement, verification or partnership unless explicitly stated.

We use cookies to improve your experience. Essential cookies are always active. You may accept optional analytics cookies or continue with essential cookies only. Privacy Policy